Elmer Santos

2.2k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Elmer Santos is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Elmer Santos has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Elmer Santos's work include CAR-T cell therapy research (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cervical Cancer and HPV Research (5 papers). Elmer Santos is often cited by papers focused on CAR-T cell therapy research (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cervical Cancer and HPV Research (5 papers). Elmer Santos collaborates with scholars based in United States, United Kingdom and Japan. Elmer Santos's co-authors include Steven M. Larson, Michel Sadelain, Renier J. Brentjens, Clay Lyddane, Isabelle Rivière, Michael Gong, Philip D. King, Mark A. Weiss, Jean‐Baptiste Latouche and Francesc Martí and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Elmer Santos

22 papers receiving 1.6k citations

Hit Papers

Eradication of systemic B-cell tumors by genetically targ... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers

Elmer Santos
Mio Kitano United States
Sara Bobisse Switzerland
Amer Najjar United States
Wei‐Zen Wei United States
Elena Sotillo United States
Natalia Lapteva United States
Linjie Guo United States
Blythe Sather United States
Ekaterina Doubrovina United States
Mio Kitano United States
Elmer Santos
Citations per year, relative to Elmer Santos Elmer Santos (= 1×) peers Mio Kitano

Countries citing papers authored by Elmer Santos

Since Specialization
Citations

This map shows the geographic impact of Elmer Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elmer Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elmer Santos more than expected).

Fields of papers citing papers by Elmer Santos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elmer Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elmer Santos. The network helps show where Elmer Santos may publish in the future.

Co-authorship network of co-authors of Elmer Santos

This figure shows the co-authorship network connecting the top 25 collaborators of Elmer Santos. A scholar is included among the top collaborators of Elmer Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elmer Santos. Elmer Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Mai, Vincenzo Paolillo, Jossana A. Damasco, et al.. (2019). Fully automated preparation of 68Ga-PSMA-11 at curie level quantity using cyclotron-produced 68Ga for clinical applications. Applied Radiation and Isotopes. 155. 108936–108936. 14 indexed citations
2.
Subbiah, Vivek, William D. Erwin, Osama Mawlawi, et al.. (2018). Abstract CT128: Phase 1 study of FF-21101(90Y), a radioimmunotherapeutic (RIT) targeting P-cadherin, in advanced solid tumors. Cancer Research. 78(13_Supplement). CT128–CT128. 1 indexed citations
3.
Subbiah, Vivek, William D. Erwin, Osama Mawlawi, et al.. (2017). Abstract CT097: Phase 1 study of FF-21101(90Y), a radioimmunotherapeutic targeting P-cadherin, in advanced solid tumors. Cancer Research. 77(13_Supplement). CT097–CT097.
4.
Santos, Elmer, Daniel L.J. Thorek, Susan Evans‐Axelsson, et al.. (2014). Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution. Nuclear Medicine and Biology. 42(4). 375–380. 8 indexed citations
5.
Chakravarty, Debyani, Elmer Santos, Mabel Ryder, et al.. (2011). Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. Journal of Clinical Investigation. 121(12). 4700–4711. 286 indexed citations
6.
Doubrovin, Mikhail, Elmer Santos, Darren R. Veach, et al.. (2010). 124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo. Journal of Nuclear Medicine. 51(1). 121–129. 8 indexed citations
7.
Veach, Darren R., Mohammad Namavari, Nagavarakishore Pillarsetty, et al.. (2007). Synthesis and Biological Evaluation of a Fluorine-18 Derivative of Dasatinib. Journal of Medicinal Chemistry. 50(23). 5853–5857. 31 indexed citations
8.
Brentjens, Renier J., Elmer Santos, Yan Nikhamin, et al.. (2007). Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts. Clinical Cancer Research. 13(18). 5426–5435. 356 indexed citations
9.
Lyddane, Clay, Beata Gajewska, Elmer Santos, et al.. (2006). Cutting Edge: CD28 Controls Dominant Regulatory T Cell Activity during Active Immunization. The Journal of Immunology. 176(6). 3306–3310. 14 indexed citations
10.
Förster, Gregor J., Elmer Santos, Peter Smith‐Jones, Pat Zanzonico, & Steven M. Larson. (2006). Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.. PubMed. 47(1). 140–9. 46 indexed citations
11.
Zhong, Xiaosong, Maiko Matsushita, Aurore Saudemont, Elmer Santos, & Michel Sadelain. (2006). 269. Integrated CD28 and 4-1BB Signals Strongly Potentiate CD8+ T Cell Mediated radication of Metastatic Prostate Cancer. Molecular Therapy. 13. S103–S103. 2 indexed citations
12.
Gade, T., Waleed Hassen, Elmer Santos, et al.. (2005). Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes. Cancer Research. 65(19). 9080–9088. 93 indexed citations
13.
Schultz, Loren D., Ling Chen, Fubao Wang, et al.. (2005). Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes. Virology. 336(2). 208–218. 27 indexed citations
14.
Zanzonico, Pat, Mark Dunphy, Gregor J. Förster, et al.. (2004). 1094-152 Suppression of physiological myocardial fluorodeoxyglucose uptake. Journal of the American College of Cardiology. 43(5). A337–A337. 3 indexed citations
15.
Brentjens, Renier J., Jean‐Baptiste Latouche, Elmer Santos, et al.. (2003). Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nature Medicine. 9(3). 279–286. 513 indexed citations breakdown →
17.
Moore, Andrew, Philip K. Nicholls, Elmer Santos, Gerald W. Gough, & Margaret Stanley. (2002). Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination. Journal of General Virology. 83(9). 2299–2301. 20 indexed citations
18.
Stanley, Margaret, Andrew Moore, Philip K. Nicholls, et al.. (2001). Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.. Vaccine. 19(20-22). 2783–2792. 54 indexed citations
19.
Nicholls, Philip K., Brenda Klaunberg, Richard A. Moore, et al.. (1999). Naturally Occurring, Nonregressing Canine Oral Papillomavirus Infection: Host Immunity, Virus Characterization, and Experimental Infection. Virology. 265(2). 365–374. 64 indexed citations
20.
Storb, R, et al.. (1981). Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease.. PubMed. 13(1 Pt 1). 237–40. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026